Stock in Focus: Apple (NASDAQ AAPL) Has A Great Week Despite Supply Fears

Apple Inc (NASDAQ AAPL) should see a higher average selling price for the iPhone this year, thanks to a number of factors, according to analysts at Stifel. Also Cantor Fitzgerald analysts say Apple executed very well in the iPhone 6 and 6 Plus opening weekend—despite the odds stacked against it. Analysts continue to weigh in on Apple Inc.’s opening weekend for the iPhone 6 and … Continue reading Stock in Focus: Apple (NASDAQ AAPL) Has A Great Week Despite Supply Fears

Stock in News: Google (NASDAQ GOOG) Says No to A Conservative Climate Change Group

A conservative political group which Google Inc (NASDAQ GOOG) was supporting lost their support for “literally lying” about global warming, following a move by Microsoft Corporation (NASDAQ MSFT) in August to pull the plug on funding. Exit from ALEC also reveals attempts by tech giants to oppose U.S. government spying on citizens without a warrant. Google executive chairman Eric Schmidt, speaking with National Public Radio, … Continue reading Stock in News: Google (NASDAQ GOOG) Says No to A Conservative Climate Change Group

Active Stock: Facebook (NASDAQ FB) To Launch a New Ad Tool

Facebook Inc (NASDAQ FB) will launch a new online advertising service next week to help advertisers in targeting and measuring the impact of their commercials, which could help the company gain market share from Google, according to the Wall Street Journal. Facebook would introduce new feature to replace Cookies for tracking ad performance. According to the report, the new ad feature will be known as … Continue reading Active Stock: Facebook (NASDAQ FB) To Launch a New Ad Tool

Biotechnology Stockmarket Biotech

Biotech Stock in Focus: Medivation-Astellas’ Xtandi’s Label Expanded

Medivation, Inc (MDVN) and partner Astellas Pharma Inc (ALPMY) received a major boost with the FDA expanding the label of their prostate cancer treatment, Xtandi. Xtandi, which was earlier approved for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC) who had previously received docetaxel (chemotherapy), can now be used in patients with metastatic CRPC who have not received chemotherapy. The prostate cancer market … Continue reading Biotech Stock in Focus: Medivation-Astellas’ Xtandi’s Label Expanded

Bitcoin News: Belgium Says Bitcoin Not Subject to VAT

Belgium’s Federal Public Service Finance (FPS) has issued a new statement finding that domestic digital currency transactions are currently not subject to value-added tax (VAT). The ruling from the tax body was revealed in an email to local digital exchange Belgacoin, which was concerned it would need to pay VAT on digital currency trades. An FPS spokesperson confirmed that bitcoin transactions are currently exempt from … Continue reading Bitcoin News: Belgium Says Bitcoin Not Subject to VAT

Stock in News: A Look At Microsoft (NASDAQ MSFT) Keyboard

Microsoft Corporation (NASDAQ MSFT) is branching out by creating universal products. The company just introduced a universal mobile keyboard which will work with many different products including iPad, iPhone, Android products, and Windows tablets. The keyboard will launch in October with the estimated retail price of $79.95. Microsoft recently introduced a universal keyboard that works with select iOS, Android, and Windows mobile devices. This particular … Continue reading Stock in News: A Look At Microsoft (NASDAQ MSFT) Keyboard